143 related articles for article (PubMed ID: 32141560)
21. LncRNA RUSC1-AS1 promotes the proliferation of breast cancer cells by epigenetic silence of KLF2 and CDKN1A.
Hu CC; Liang YW; Hu JL; Liu LF; Liang JW; Wang R
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6602-6611. PubMed ID: 31378902
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-9501 inhibits breast cancer proliferation and metastasis through regulating Wnt/β-catenin pathway.
Que LM; Yang XR; Zhang YC; Zhong H
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4337-4347. PubMed ID: 32373971
[TBL] [Abstract][Full Text] [Related]
23. LncRNA DLEU1/microRNA-300/RAB22A axis regulates migration and invasion of breast cancer cells.
Wang C; Xie XX; Li WJ; Jiang DQ
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10410-10421. PubMed ID: 31841195
[TBL] [Abstract][Full Text] [Related]
24. LncRNA HOXA-AS2 accelerates the proliferation and migration and inhibits the apoptosis of vascular smooth muscle cells by absorbing miRNA-877-3p.
Fan TT; Liu YX; Wang XC; Xu BL; Chen ZC; Lu HA; Zhang M
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):362-368. PubMed ID: 31957850
[TBL] [Abstract][Full Text] [Related]
25. Mechanism of LncRNA FOXC2-AC1 promoting lung cancer metastasis by regulating miR-107.
Wu XF; Lu JT; Chen W; Wang N; Meng JC; Zhou YH
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):690-698. PubMed ID: 30720176
[TBL] [Abstract][Full Text] [Related]
26. LncRNA HOTAIR promotes colon cancer development by down-regulating miRNA-34a.
Peng CL; Zhao XJ; Wei CC; Wu JW
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5752-5761. PubMed ID: 31298326
[TBL] [Abstract][Full Text] [Related]
27. MiRNA-96 accelerates the malignant progression of ovarian cancer via targeting FOXO3a.
Yang N; Zhang Q; Bi XJ
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):65-73. PubMed ID: 31957819
[TBL] [Abstract][Full Text] [Related]
28. LncRNA MAGI2-AS3 suppresses the proliferation and invasion of non-small cell lung carcinoma through miRNA-23a-3p/PTEN axis.
Hao XZ; Yang K
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7399-7407. PubMed ID: 31539127
[TBL] [Abstract][Full Text] [Related]
29. LncRNA CASC19 promotes the proliferation, migration and invasion of non-small cell lung carcinoma via regulating miRNA-130b-3p.
Qu CX; Shi XC; Zai LQ; Bi H; Yang Q
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):247-255. PubMed ID: 31389608
[TBL] [Abstract][Full Text] [Related]
30. LncRNA SND1-IT1 accelerates the proliferation and migration of osteosarcoma via sponging miRNA-665 to upregulate POU2F1.
Jin XM; Xu B; Zhang Y; Liu SY; Shao J; Wu L; Tang JA; Yin T; Fan XB; Yang TY
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9772-9780. PubMed ID: 31799644
[TBL] [Abstract][Full Text] [Related]
31. Circular RNA hsa_circ_0068871 regulates FGFR3 expression and activates STAT3 by targeting miR-181a-5p to promote bladder cancer progression.
Mao W; Huang X; Wang L; Zhang Z; Liu M; Li Y; Luo M; Yao X; Fan J; Geng J
J Exp Clin Cancer Res; 2019 Apr; 38(1):169. PubMed ID: 30999937
[TBL] [Abstract][Full Text] [Related]
32. Circ0021205 aggravates the progression of non-small cell lung cancer by targeting miRNA-16-5p/VEGFA.
Yang Y; Huang XJ
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):213-221. PubMed ID: 31957834
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-765 alleviates the malignant progression of breast cancer via interacting with EZH1.
Zeng Z; Yang Y; Wu H
Am J Transl Res; 2019; 11(7):4500-4507. PubMed ID: 31396353
[TBL] [Abstract][Full Text] [Related]
34. LncSNHG16 promotes proliferation and migration of osteosarcoma cells by targeting microRNA-146a-5p.
Zheng SN; Ge DW; Tang J; Yang J; Yan JW; Qiu JJ; Yin ZW; Ni Y; Zhao L; Chen X; Yang L
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):96-104. PubMed ID: 30657551
[TBL] [Abstract][Full Text] [Related]
35. Effect of the LncRNA GAS5-MiR-23a-ATG3 Axis in Regulating Autophagy in Patients with Breast Cancer.
Gu J; Wang Y; Wang X; Zhou D; Wang X; Zhou M; He Z
Cell Physiol Biochem; 2018; 48(1):194-207. PubMed ID: 30007957
[TBL] [Abstract][Full Text] [Related]
36. circ-FNTA accelerates proliferation and invasion of bladder cancer.
Tian J; Fan J; Xu J; Ren T; Guo H; Zhou L
Oncol Lett; 2020 Jan; 19(1):1017-1023. PubMed ID: 31897215
[TBL] [Abstract][Full Text] [Related]
37. LINC00346 accelerates the malignant progression of colorectal cancer via competitively binding to miRNA-101-5p/MMP9.
Tong WH; Mu JF; Zhang SP
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6639-6646. PubMed ID: 32633353
[TBL] [Abstract][Full Text] [Related]
38. LncRNA FAL1 promotes the development of oral squamous cell carcinoma through regulating the microRNA-761/CRKL pathway.
Ye J; Jiao Y
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5779-5786. PubMed ID: 31298329
[TBL] [Abstract][Full Text] [Related]
39. Long non-coding RNA LINC00662 promotes proliferation and migration of breast cancer cells via regulating the miR-497-5p/EglN2 axis.
Cheng L; Xing Z; Zhang P; Xu W
Acta Biochim Pol; 2020 Jun; 67(2):229-237. PubMed ID: 32558530
[TBL] [Abstract][Full Text] [Related]
40. LncRNA TATDN1 induces the progression of hepatocellular carcinoma via targeting miRNA-6089.
Shen C; Xu Y; Lu TF; Zhang JJ; Qian YB; Xu N
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6459-6466. PubMed ID: 31378885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
